Immunothérapie anti-tumorale contre la multidrogue résistance

Endicott, 1989, The biochemistry of P-glycoprotein-mediated multidrug resistance, Annu Rev Biochem, 58, 137, 10.1146/annurev.bi.58.070189.001033 Moscow, 1990, Multidrug resistance, Cancer Chemother Biol Resp Modif, 11, 97 Chen, 1986, Internal duplication and homology with bacterial transport proteins in the mdr-1 (P-glycoprotein) gene from multidrug-resistant human cells, Cell, 47, 381, 10.1016/0092-8674(86)90595-7 Devault, 1990, Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities, Mol Cell Biol, 10, 1652, 10.1128/MCB.10.4.1652 Hyde, 1990, Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport, Nature, 346, 362, 10.1038/346362a0 Roninson, 1992, The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo, Biochem Pharmacol, 43, 95, 10.1016/0006-2952(92)90666-7 Hegmann, 1992, Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells, Cancer Res, 52, 6969 Schinkel, 1994, Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs, Cell, 77, 491, 10.1016/0092-8674(94)90212-7 Schinkel, 1993, Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P-glycoprotein, Int J Cancer, 30, 478, 10.1002/ijc.2910550326 Mechetner, 1992, Efficient inhibition of P-glycoprotein mediated multidrug resistance with a monoclonal antibody, Proc Natl Acad Sci USA, 89, 5824, 10.1073/pnas.89.13.5824 Gros, 1986, Mammalian drug resistance gene: complete cDNA sequence indicates a strong homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug resistant human cells, Cell, 47, 371, 10.1016/0092-8674(86)90594-5 Smit, 1993, Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease, Cell, 75, 451, 10.1016/0092-8674(93)90380-9 Tosi, 1995, Immune response against the murine mdr1 protein induced by vaccination with synthetic lipopeptides in liposomes, Biochem Biophys Res Com, 212, 494, 10.1006/bbrc.1995.1997 Nicolau, 2002, A liposome-based therapeutic vaccine against β-amyloid plaques on the pancreas of transgenic NORBA mice, Proc Natl Acad Sci, 99, 2332, 10.1073/pnas.022627199 Richards, 1988, Liposomes, lipid A and aluminium hydroxide enhance the immune response to a synthetic malaria sporozoite antigen, Infect Immun, 56, 682, 10.1128/IAI.56.3.682-686.1988 Gros, 1993, The mouse multidrug resistance gene family: Structural and functional analysis, Int Rev Cyto, 137C, 169 Merrifield, 1963, Solid phase peptide synthesis. The synthesis of a tetrapeptide, J Am Chem Soc, 85, 2149, 10.1021/ja00897a025 Merrifield, 1986, Solid phase synthesis, Science, 232, 341, 10.1126/science.3961484 Schnölzer, 1992, In situ neutralization in Boc-chemistry solid phase peptide synthesis, Int J Peptide Protein Res, 40, 180, 10.1111/j.1399-3011.1992.tb00291.x Fries, 1992, Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy, Proc Natl Acad Sci USA, 89, 358, 10.1073/pnas.89.1.358 Jiao, 1992, A new 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for testing macrophage cytotoxicity to L1210 and its drug-resistant cell lines in vitro, Cancer Immunol Immunother, 35, 412, 10.1007/BF01789020 Grant, 1981, Effect of N-(phosphonacetyl)-L-aspartate on S-azacytidine metabolism in P388 and L1210 cells, Cancer Res, 41, 410 Lum, 1993, Molecular targets in oncology: implications of the multidrug resistance gene, Pharmacotherapy, 13, 88 Ford, 1990, Pharmacology of drugs that alter multidrug resistance in cancer, Pharmacol Rev, 42, 155 Figueredo, 1990, Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer. A phase I/II study, Cancer, 65, 1895, 10.1002/1097-0142(19900501)65:9<1895::AID-CNCR2820650904>3.0.CO;2-R Solary, 1992, Feasibility of using quinine, a potential multidrug resistance-reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia, Clin Oncol, 10, 1730, 10.1200/JCO.1992.10.11.1730 Trump, 1992, High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine, J Natl Cancer Inst, 84, 1811, 10.1093/jnci/84.23.1811 Beck, 1991, 3 Hebell, 1991, Suppression of the immune response by a soluble complement receptor of B lymphocytes, Science, 254, 102, 10.1126/science.1718035 Swartz, 1988, Antibodies to cholesterol, Proc Natl Acad Sci USA, 85, 1902, 10.1073/pnas.85.6.1902 Edelman, 1980, Vaccine adjuvants, Rev Infect Dis, 2, 370, 10.1093/clinids/2.3.370 Watari, 1987, A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2, J Exp Med, 165, 459, 10.1084/jem.165.2.459 Deres, 1989, In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine, Nature, 342, 561, 10.1038/342561a0 Bourgault, 1994, Simian immunodeficiency virus as a model for vaccination against HIV, J Immunol, 152, 2530, 10.4049/jimmunol.152.5.2530 Miller, 1991, P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil, J Clin Oncol, 9, 17, 10.1200/JCO.1991.9.1.17 Pierré, 1992, In vitro and in vivo circumvention of multidrug resistance by servier 9788, a novel triazinoaminopiperidine derivative, Invest New Drug, 10, 137, 10.1007/BF00877238 Beck, 1991, Do anti-P-glycoprotein antibodies have a future in the circumvention of multidrug resistance?, J Natl Cancer Inst, 83, 1364, 10.1093/jnci/83.19.1364 Gottesman, 1993, Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu Rev Biochem, 62, 385, 10.1146/annurev.bi.62.070193.002125 Broxterman, 1988, Increase of daunorubicin and vincristine accumulation in multidrug resistant human ovarian carcinoma cells by a monoclonal antibody reacting with P-glycoprotein, Biochem Pharmacol, 37, 2389, 10.1016/0006-2952(88)90365-6 Chan, 1997, P-glycoprotein expression: critical determinant in the response to osteosarcoma chemotherapy, J Natl Cancer Inst, 89, 1706, 10.1093/jnci/89.22.1706 Efferth, 1992, Antibody-directed therapy of multidrug-resistant tumor cells, Med Oncol Tumor Pharmacother, 9, 11, 10.1007/BF02989648 Cole, 1992, Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line, Science, 258, 1650, 10.1126/science.1360704 Baselga, 1996, Phase II study of weekly intravenous recombinant humanised anti-p185 HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast, J Clin Oncol, 14, 737, 10.1200/JCO.1996.14.3.737